Skip to main content
(352) 733-0111

Clinical trials

  • R131L1265-HEMB-2318; BEYOND-9

    Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study is researching an experimental gene insertion therapy (the adding of…

    Investigator
    Tung T Wynn
    Ages
    2 Years - N/A
    Sexes
    Male
  • R0000-HEMB-2187: HONEY-B

    This study is focused on males who have Hemophilia B and who need regular preventive treatment with factor IX protein (FIX) replacement therapy to prevent and also to control their bleeding events. The aim of the study is to gather at least 6 months…

    Investigator
    Tung T Wynn
    Ages
    16 Years - N/A
    Sexes
    Male